In this study, we evaluated the peripheral B cell subsets, especially Breg cells in IgG4-RD patients, pSS patients, and HC, as well as B cell co-stimulatory and activation markers of CD80, CD86, CD40, and B cell activating factor receptor expression. This evidence concerns the gene TNFRSF13C and immunoglobulin G4-related sclerosing disease.